Skip to main content
main-content

Type 2 diabetes and glycemic control

EASD 2020

COVID-19 and diabetes: The current evidence

Juliana Chan

Juliana Chan outlines current knowledge about the relationship between diabetes and COVID-19, discussing risk factors for poor outcomes in people with both conditions and the need for collaborative efforts to improve patient care (7:09).

medwireNews top story

‘Nearly identical’ metabolic benefits with surgery vs diet in people with type 2 diabetes

Bariatric surgery

Among people with obesity and type 2 diabetes, substantial weight loss is associated with similar metabolic benefits irrespective of whether it is achieved through gastric bypass surgery or diet, suggests research published in The New England Journal of Medicine.

medwireNews top story

Type 1, type 2 diabetes linked to elevated COVID-19 mortality risk

Doctor checking on Covid-19 infected patient connected to a ventilator

Both type 1 and type 2 diabetes are independently associated with an increased risk for death among hospitalized patients with COVID-19, and a number of factors including poor glycemic control and BMI may predict mortality risk, suggest findings from two studies published in The Lancet Diabetes & Endocrinology.

medwireNews top story

Severe hypoglycemia ‘marker rather than cause’ for longer-term type 2 diabetes mortality risk

emergency_department

Severe hypoglycemia in people with type 2 diabetes is associated with later mortality from a wide range of causes, including those for which there is no obvious underlying mechanism, say researchers.

medwireNews top story

Haptoglobin genotype may dictate success of intensive glucose control

Blood test

The benefits and harms of intensive glucose control in people with type 2 diabetes may depend on which form of haptoglobin they have, shows an analysis of the ACCORD trial.

Expert opinion

Exposure to diabetes technologies: Where now for adult services?

Exposure to diabetes technologies: Where now for adult services?

What does the proliferation of diabetes self-management and monitoring technologies in pediatric care mean for the future of adult services? Katharine Barnard looks at the situation in England. 

Get more on: Devices and technology | Pediatric diabetes

medwireNews editor's pick

Adding second diabetes medication better than switching in face of poor response

Addition

Adding an additional glucose-lowering medication is better than switching to a different one in people with type 2 diabetes, even if the original seemed to have little or no effect, shows an analysis from the MASTERMIND consortium.

Expert opinion editorial

Diabetes and dementia: Addressing the needs of an overlooked population

Diabetes and dementia: Addressing the needs of an overlooked population

Diabetologist Amar Puttanna addresses growing concerns about the rise of dementia in diabetes care and highlights where guidelines, research efforts, and management options are needed to tackle this comorbidity [read more].

Get more on: Mental health and diabetesDiabetes complications and comorbidities | Diabetes in older adults

medwireNews top story

d-Nav system helps people with type 2 diabetes optimize insulin doses

Compass

The d-Nav system, which calculates insulin dose adjustments according to glucose levels, can help people with type 2 diabetes achieve larger reductions in glycated hemoglobin levels than with healthcare professional support alone, shows a randomized trial in The Lancet.

medwireNews editor's pick

Hepatic glucokinase activation may improve glycemic control in type 2 diabetes

Pills_yellow

The hepatoselective glucokinase activator TTP399 reduces glycated hemoglobin levels without increasing the risk for hypoglycemia among patients with type 2 diabetes, suggest findings from the phase IIb AGATA trial.

medwireNews

11-10-2020 | Mobile technology | News

Text intervention alone insufficient to sustain type 2 diabetes improvements

A tailored text messaging intervention might help lower glycated hemoglobin levels in people with type 2 diabetes in the short-term, but additional support may be needed for sustained improvements, US study data show.

10-29-2020 | Nephropathy | News

Improving glycemic control may reduce AKI risk in people with type 2 diabetes, CKD

Poor glycemic control is associated with acute kidney injury risk in people with type 2 diabetes and chronic kidney disease, according to results from an observational study.

09-04-2020 | Glycemic control | News

High usual HbA1c raises cardiovascular risk in type 2 diabetes

The risk for someone with type 2 diabetes experiencing a cardiovascular disease event increases by 21% for every 1% increase in their usual glycated hemoglobin level above 7.0%, study findings suggest.

Downloadable slides

10-31-2018 | Slideset | Collection

FreeStyle Libre collection

These slide sets summarize the results of clinical studies and randomized controlled trials investigating the use of flash glucose-sensing technology in patients with diabetes.

Funded by an educational grant from Abbott Diabetes Care

Themed collections

07-31-2017 | Metabolic surgery | Themed collection | Collection

Metabolic surgery in diabetes

This content collection examines the mechanisms associated with diabetes remission following bariatric (metabolic) surgery, considers the patients most suitable for each procedure, and reviews post-surgical management and outcomes, including complications.

Journal articles and book chapters

07-17-2020 | Flash glucose monitoring | Article

The Impact of Flash Glucose Monitoring on Glycaemic Control as Measured by HbA1c: A Meta-analysis of Clinical Trials and Real-World Observational Studies

The authors report on ameta-analysis of real-world observational studies on the impact of flash continuous glucose monitoring on glycemic control as measured by HbA1c.

11-06-2018 | Diabetes self-management | Article

Exploring how patients understand and assess their diabetes control

Gopalan A et al. BMC Endocr Disord 2018; 18: 79. doi: 10.1186/s12902-018-0309-4

11-03-2018 | Liraglutide (T2DM) | Article

Liraglutide and glycemic outcomes in the LEADER trial

Zinman B et al. Diabetes Ther 2018. doi: 10.1007/s13300-018-0524-z

09-14-2018 | Insulin glargine/Lixisenatide | Article

Bedtime-to-morning glucose difference and iGlarLixi in type 2 diabetes: Post hoc analysis of LixiLan-L

Zisman A et al. Diabetes Ther 2018. doi: 10.1007/s13300-018-0507-0

09-13-2018 | Pathophysiology | Review | Article

Altered gut microbiota in type 2 diabetes: Just a coincidence?

Sircana A et al. Curr Diab Rep 2018; 18: 98. doi: 10.1007/s11892-018-1057-6

Guidelines

A convenient single access point, providing diabetes professionals with links to a comprehensive set of clinical practice guidelines from a wide range of relevant organizations.

Slides

Downloadable PowerPoint slide sets containing a variety of high-quality images and illustrations from Springer Nature’s library of published figures.

Practice tips

Practical information, guidance, and helpful resources for diabetes healthcare providers. Comprised of practical approaches, case studies, and more.

Themed collections

Compendia of selected, recently published, free full-text journal and book content from Springer Nature and other publishers on a particular topic within diabetes management, as recommended by our Editorial Board.

Independent Medical Education

Educational programs building upon the most current research and professional practice recommendations, with the aim of enabling more efficient diagnosis, optimizing treatment, and improving patient outcomes.

Image Credits